US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

240.49

+0.99820.42%

Volume:47.79K

Turnover:11.50M

Market Cap:477.73M

PE:- -

High:241.58

Open:239.94

Low:239.85

Close:239.49

52wk High:244.35

52wk Low:160.91

Shares:1.99M

Float Shares:1.99M

Volume Ratio:5.45

T/O Rate:2.41%

Dividend:0.95

Dividend Rate:0.39%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints

AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients

MT Newswires Live

Vertex Corp. Added to JPX-Nikkei Mid and Small Cap Index for FY2026

Vertex Corp. Refines Leadership Structure at Key Subsidiary Vertex Co.

AstraZeneca-Amgen Asthma Drug Succeeds in Late-Stage Oesophagus Disease Trial

Amgen - Tezspire Safety Profile Consistent with Approved Indications

THOMSON REUTERS

Tezspire® Demonstrates Positive Phase 3 Results in Eosinophilic Esophagitis Across Both Co-Primary and All Key Secondary Endpoints

THOMSON REUTERS

Revolution Medicines, Inc. : Oppenheimer Raises Target Price to $260 from $230

THOMSON REUTERS

Moderna Inc. Stock Falls 5.8%, Underperforms Peers

Gilead Sciences Updates Financial Calendar with Investor Conference Presentations

Vertex to Present at Wells Fargo Healthcare Investor Conference Fireside Chat

Revolution Medicines Prices Metastatic Pancreatic Cancer Drug Rasonque at $39,800 a Month

MT Newswires Live

Revolution Medicines to Charge $39,800 a Month for Pancreatic Cancer Drug, Bloomberg Reports

MT Newswires Live

Revolution Medicines - Rasonque is NOW Commercially Available in the U.S. at a Wholesale Acquisition Cost of $39,800 for a 30-Day Supply - Conf Call

THOMSON REUTERS

Revolution Medicines Posts Investor Presentation on Rasonque FDA Approval

Revolution Medicines prices Rasonque at $39,800 for 30-day supply

Revolution Medicines announces FDA approval of Rasonque in adults

Revolution Medicines, - Rasonque 300 Mg Once-Daily Oral Tablets NOW Available in the U.S.

THOMSON REUTERS

U.S. FDA Approves Revolution Medicines’ Rasonque™ (Daraxonrasib), the First Broad Ras-Targeted Medicine in Metastatic Pancreatic Cancer

THOMSON REUTERS

U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/BBH/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":240.49,"timestamp":1788374054867,"preClose":239.4918,"halted":0,"volume":47790,"delay":0,"changeRate":0.004167992390553652,"floatShares":1986503,"shares":1986503,"eps":0,"marketStatus":"Trading","change":0.9982,"latestTime":"09-02 14:38:06 EDT","open":239.94,"high":241.58,"low":239.85,"amount":11495836.71,"amplitude":0.007224,"askPrice":242.42,"askSize":200,"bidPrice":242.2,"bidSize":150,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788379200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":239.4918,"sharesOutstanding":1976503,"nav":236.27832,"aum":469367592.63,"dividendRate":0.003933,"bidAskSpread":0.001117,"preHourTrading":{"tag":"盘前","latestPrice":239.49,"preClose":239.4918,"latestTime":"04:56 EDT","volume":1,"amount":239.49,"timestamp":1788339417440,"change":-0.0018,"changeRate":-0.000008,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":239.0965,"preClose":239.4918,"latestTime":"16:23 EDT","volume":18,"amount":4311.9544,"timestamp":1788294232639,"change":-0.3953,"changeRate":-0.001651,"amplitude":0},"volumeRatio":5.448044,"impliedVol":0.1939,"impliedVolPercentile":0.504},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","floatShares":1986503,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":5.448044,"shares":1986503,"dividePrice":0.9459,"high":241.58,"amplitude":0.007224,"preClose":239.4918,"low":239.85,"week52Low":160.91,"pbRate":"--","week52High":244.345,"institutionHeld":0,"latestPrice":240.49,"committee":-0.142857,"eps":0,"divideRate":0.003933,"volume":47790,"delay":0,"ttmEps":0,"open":239.94,"prevYearClose":189.2649,"prevWeekClose":236.4764,"prevMonthClose":236.396,"prevQuarterClose":203.2373,"fiveDayClose":242.67,"twentyDayClose":210.4939,"sixtyDayClose":186.0541},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBH","amount":0.9565,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-12-23","symbol":"BBH","amount":1.2517,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-24"},{"date":"2023-12-18","symbol":"BBH","amount":0.7127,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"VanEck Biotech ETF","recordDate":"2023-12-22","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-22"},{"market":"US","date":"2022-12-19","symbol":"BBH","amount":0.7488,"defaultRemindTime":1671460200000,"name":"VanEck Biotech ETF","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"BBH","amount":0.3972,"defaultRemindTime":1640010600000,"name":"VanEck Vectors Biotech ETF","recordDate":"2021-12-27","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-19","recordDate":"2016-12-21","paymentDate":"2016-12-23","value":0.327,"currency":"USD"},{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.006,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-30","value":0.4724,"currency":"USD"},{"executeDate":"2020-12-21","recordDate":"2020-12-22","paymentDate":"2020-12-28","value":0.6079,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-27","value":0.3972,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBH\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662877754","title":"Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2662877754","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662877754?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:15","pubTimestamp":1787822113,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 CROSSING trial of Tezspire in patients living with eosinophilic esop...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-report-crossing-trial-met-co-primary-and-secondary-endpoints-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-report-crossing-trial-met-co-primary-and-secondary-endpoints-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AZN","BBH","LU0029864427.USD","LU1023059063.AUD","PJP","LU1983299246.USD","BK4599","IBB","LU1267930573.SGD","LU2456880835.USD","PBE","LU2237443465.HKD","BK4533","LU0128525929.USD","BK4585","AMGN","LU1829250122.USD","BIB","LU0889565916.HKD","IE00BJT1NW94.SGD","LU2417539215.USD","LU1061106388.HKD","TBXU","IE0002141913.USD","LU0320765992.SGD","IE00BFTCPJ56.SGD","IE00B3T34201.USD","LU2236285917.USD","LU2237443895.HKD","LU2237443978.SGD","BK4588","BK4568","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU2112291526.USD","LU2242646821.SGD","IBBQ","BK4007","LU0122379950.USD","AZNH","LU0289739699.SGD","BK4581","LU0432979614.USD","LU0058720904.USD","IE00B2B36J28.USD","LU2468319806.SGD","IE0009355771.USD","LU1571399168.USD","LU0868494617.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662771175","title":"AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2662771175","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662771175?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:24","pubTimestamp":1787819085,"startTime":"0","endTime":"0","summary":"AstraZeneca  and Amgen  said Thursday their drug Tezspire met the primary endpoints of a Phase 3 trial treating eosinophilic esophagitis, a chronic inflammatory esophagus disorder.The medication met both primary endpoints by reducing tissue inflammation and easing swallowing difficulties at week 24 compared to a placebo, the companies said.The disease and symptom improvements were maintained through week 52 for both tested doses, they said.The companies also said the safety profile of the treatment during the study remained consistent with its previously approved uses.Shares of Amgen were down by over 1% in Thursday premarket activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TBXU","AZNH","IE00B4R5TH58.HKD","BK4534","LU2462157665.USD","LU2237443622.USD","LU2242652126.USD","LU0058720904.USD","LU0889565916.HKD","BBH","LU2242646821.SGD","BK4533","PJP","LU0708994859.HKD","BK4585","LU2089984988.USD","LU2237443465.HKD","LU1057294990.SGD","LU1061106388.HKD","LU2237443978.SGD","LU2112291526.USD","LU2237443895.HKD","LU0128525929.USD","LU1267930573.SGD","BK4566","IE00BJT1NW94.SGD","LU2456880835.USD","IE00BFTCPJ56.SGD","LU0432979614.USD","LU1829250122.USD","BK4599","LU0029864427.USD","LU0310800379.SGD","AMGN","BIB","BK4581","IBBQ","AZN","IBB","LU0109394709.USD","LU2237443382.USD","LU0868494617.USD","LU1571399168.USD","IE00B2B36J28.USD","PBE","BK4007","LU2237443549.SGD","LU1983299246.USD","IE00BJJMRZ35.SGD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662775710","title":"Vertex Corp. Added to JPX-Nikkei Mid and Small Cap Index for FY2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662775710","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662775710?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:55","pubTimestamp":1787813720,"startTime":"0","endTime":"0","summary":"The latest update is out from Vertex Corp. ( ($JP:5290) ). Vertex Corporation has been selected as a constituent of the JPX-Nikkei Mid and Small Ca...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-corp-added-to-jpx-nikkei-mid-and-small-cap-index-for-fy2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-corp-added-to-jpx-nikkei-mid-and-small-cap-index-for-fy2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VRTX","IE00B2B36J28.USD","LU2468319806.SGD","IE00BZ9MQY76.HKD","LU2462157665.USD","VERX","BK4567","IE00B19Z9Z06.USD","IE00BFTCPJ56.SGD","LU0289739699.SGD","IBB","IBBQ","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0058720904.USD","BK4533","LU1585245621.USD","PBE","BIB","IE0002141913.USD","IE00B19Z3581.USD","LU2089984988.USD","IE00B19Z9P08.USD","IE00BJT1NW94.SGD","LU1069344957.HKD","LU1559883803.SGD","LU1815336091.USD","LU0566484027.USD","JPX","BK4532","BBH","SG9999013999.USD","LU0432979614.USD","TBXU","IE0002270589.USD","LU1093756168.USD","LU1430594728.SGD","BK4023","LU0079474960.USD","SG9999001176.USD","LU2417539215.USD","SGXZ57979304.SGD","LU2456880835.USD","LU0234570918.USD","LU0823416689.USD","LU1778281490.HKD","BK4585","IDNA","LU0109394709.USD","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662477574","title":"Vertex Corp. Refines Leadership Structure at Key Subsidiary Vertex Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2662477574","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662477574?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:55","pubTimestamp":1787813711,"startTime":"0","endTime":"0","summary":"The latest update is out from Vertex Corp. ( ($JP:5290) ). Vertex Corporation has updated its earlier disclosures on changes to directors and offic...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-corp-refines-leadership-structure-at-key-subsidiary-vertex-co?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-corp-refines-leadership-structure-at-key-subsidiary-vertex-co?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4023","LU1815336091.USD","LU0320765992.SGD","SG9999001176.USD","TBXU","VRTX","BK4532","LU0058720904.USD","LU2362541273.HKD","BBH","LU2462157665.USD","GNMX","LU0234570918.USD","BK4139","LU1035775433.USD","BIB","LU1559883803.SGD","IE00B19Z9P08.USD","BK4585","LU2362541513.USD","LU0566484027.USD","IE00BZ9MQY76.HKD","BK4567","LU1674673428.USD","LU0109394709.USD","IE00B19Z9Z06.USD","IE00B2B36J28.USD","LU0417517546.SGD","LU0256863811.USD","IBBQ","LU0889565916.HKD","IE00BJT1NW94.SGD","BK4533","LU1430594728.SGD","LU2417539215.USD","SGXZ57979304.SGD","IE0002270589.USD","IBB","LU0061475181.USD","LU0289739699.SGD","LU0757428866.USD","VERX","LU0823416689.USD","LU2456880835.USD","LU1093756325.SGD","IDNA","IE00B19Z3581.USD","LU0079474960.USD","LU2236285917.USD","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662514775","title":"AstraZeneca-Amgen Asthma Drug Succeeds in Late-Stage Oesophagus Disease Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662514775","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662514775?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:40","pubTimestamp":1787812818,"startTime":"0","endTime":"0","summary":"UPDATE 3-AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trialAug 27 (Reuters)-AstraZenecaAZN.Lsaid on Thursday its asthma drug Tezspire met the main goals of a late-stage tria","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL6N44O0DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1051770623.HKD","IBB","03165","LU1481600234.SGD","BIB","LU0997586432.USD","LU1153584641.USD","LU1571399168.USD","LU0345777659.USD","LU0997586515.USD","LU1119994496.HKD","LU1880407132.USD","LU1003077747.HKD","IE00BFTCPJ56.SGD","LU0052756011.USD","LU0738911758.USD","LU1267930490.SGD","LU2237443382.USD","AZN.UK","LU0661504455.SGD","LU0823434583.USD","LU1170363599.USD","LU1829250122.USD","LU0432979614.USD","LU2293690082.USD","LU0575583348.USD","LU0047473722.EUR","PBE","LU2242652126.USD","BBH","LU0792757196.USD","BK4588","BK4599","TBXU","LU0887340254.USD","LU1974910355.USD","LU0077335932.USD","LU1057294990.SGD","LU0266013472.USD","LU0122379950.USD","PJP","LU0310799852.SGD","AMGN","SGXZ57979304.SGD","LU0640478417.SGD","LU2237443622.USD","LU3187612489.SGD","REGN","IBBQ","LU0972486137.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662778025","title":"Amgen - Tezspire Safety Profile Consistent with Approved Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2662778025","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662778025?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA3XV48Z:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBBQ","LU1023059063.AUD","LU0868494617.USD","BBH","BK4599","LU2242646821.SGD","BK4585","BIB","IE00BJJMRZ35.SGD","LU2112291526.USD","LU0109394709.USD","LU2468319806.SGD","IE0002141913.USD","BK4588","AMGN","LU2242652126.USD","LU0889565916.HKD","LU1057294990.SGD","IE0009355771.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4533","LU1571399168.USD","PBE","BK4581","BK4534","LU0320765992.SGD","IE00BFTCPJ56.SGD","PJP","SG9999001440.SGD","IE00BJT1NW94.SGD","LU1983299246.USD","IBB","LU0122379950.USD","BK4566","LU2089984988.USD","LU0289739699.SGD","LU0058720904.USD","TBXU","LU1061106388.HKD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662728778","title":"Tezspire® Demonstrates Positive Phase 3 Results in Eosinophilic Esophagitis Across Both Co-Primary and All Key Secondary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2662728778","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662728778?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA3XV48Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0289739699.SGD","PJP","BBH","LU0868494617.USD","BK4139","LU1983299246.USD","LU2112291526.USD","BK4534","BK4588","IE00BFTCPJ56.SGD","LU0320765992.SGD","BK4533","LU2242652126.USD","IE00BJJMRZ35.SGD","LU1061106388.HKD","IBB","LU1571399168.USD","LU2242646821.SGD","LU0058720904.USD","SG9999001440.SGD","PBE","LU0889565916.HKD","LU1023059063.AUD","LU2089984988.USD","IBBQ","TBXU","LU0122379950.USD","IE00BJT1NW94.SGD","BIB","IE0002141913.USD","BK4585","AMGN","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4566","LU2468319806.SGD","LU1057294990.SGD","LU0109394709.USD","BK4599","BK4581","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662988724","title":"Revolution Medicines, Inc. : Oppenheimer Raises Target Price to $260 from $230","url":"https://stock-news.laohu8.com/highlight/detail?id=2662988724","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662988724?lang=en_us&edition=fundamental","pubTime":"2026-08-27 10:38","pubTimestamp":1787798329,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44N0VT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0109394709.USD","RVMD","IE0009354923.USD","IDNA","IE0009355771.USD","PTH","LU0320765992.SGD","BBH","IE0002141913.USD","IE00B2B36J28.USD","BK4139","IE00BFTCPJ56.SGD","LU0889565916.HKD","IE00B4R5TH58.HKD","CANC","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662440957","title":"Moderna Inc. Stock Falls 5.8%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662440957","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662440957?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:33","pubTimestamp":1787776380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slid 5.8% to $149.66 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.1% to 26,130.20 and Dow Jones Industrial Average falling 0.2% to 53,463.88.Moderna Inc. closed 15.3% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.1% to $270.00, Pfizer Inc. fell 0.9% to $28.30, and Gilead Sciences Inc. fell 0.46% to $148.09.Trading volume totaled 21.8 million, compared to the 50-day average of 16.1 million.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","BK4578","SG9999015978.USD","IBBQ","TMED","IE00B19Z3581.USD","GNOM","BK4533","BK4551","LU0320765992.SGD","LU1674673691.USD","LU2357627491.SGD","LU0058720904.USD","GILD","MEDI","MRNX","IDNA","IE00B7SZLL34.SGD","SG9999015952.SGD","LU1585245621.USD","BK4548","LU0122379950.USD","LU0861579265.USD","LU0965509101.SGD","BK4532","LGHT","IBB","LU0965508806.USD","LU0109394709.USD","LU1934455863.HKD","MRNY","LU1839511570.USD","LU2324357040.USD","LU1057294990.SGD","LU1674673428.USD","LU2087621335.USD","BMED","IE00BZ1G4Q59.USD","BK4585","IE0002270589.USD","LU1571399168.USD","BBH","WDNA","BIB","TBXU","BK4534","LU0965509283.SGD","MRNA","LU0234570918.USD","LU1037948541.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662417787","title":"Gilead Sciences Updates Financial Calendar with Investor Conference Presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=2662417787","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662417787?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:05","pubTimestamp":1787774725,"startTime":"0","endTime":"0","summary":"Gilead Sciences updates financial calendar with investor conference presentationsGilead executives will present at the Wells Fargo Annual Healthcare Conference on September 9 at 11:00 a.m. ET.Presenta","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL8cjLQm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","LU0109394709.USD","LU1037948897.HKD","IBBQ","LU0861579265.USD","LU0889565916.HKD","LU1674673691.USD","LU1934455277.USD","LU1778281490.HKD","BK4568","LU0234570918.USD","LU1585245621.USD","LU2087621335.USD","LU0122379950.USD","IE00B19Z3581.USD","BK4585","BK4588","LU0823416689.USD","BIB","IE0002270589.USD","TBXU","MEDI","IE00B3T34201.USD","LU1430594728.SGD","IE00B7SZLL34.SGD","LU2112291526.USD","BK4583","BK4550","LU0965508806.USD","LU1674673428.USD","LU1057294990.SGD","LU0859254822.USD","LU2089984988.USD","LU0965509010.AUD","IE00BZ1G4Q59.USD","LU1023059063.AUD","SG9999015952.SGD","TMED","LU1571399168.USD","LU0965509283.SGD","BBH","IBB","LU1037948541.HKD","GILD","LU0882574055.USD","BMED","LU1066053197.SGD","IE00BKVL7J92.USD","LU0289739699.SGD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662741464","title":"Vertex to Present at Wells Fargo Healthcare Investor Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2662741464","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662741464?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:00","pubTimestamp":1787774425,"startTime":"0","endTime":"0","summary":"Vertex to present at Wells Fargo healthcare investor conference fireside chatVertex will join four investor conference fireside chats in September 2026, led by senior management.Wells Fargo 21st Annua","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL7VGD1d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBE","BK4533","LU1430594728.SGD","GNMX","SGXZ57979304.SGD","LU2462157665.USD","LU2089984988.USD","BK4139","LU1069344957.HKD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU1674673691.USD","LU1093756168.USD","IE00B4R5TH58.HKD","IE00B19Z9P08.USD","IE00B19Z3581.USD","LU0417517546.SGD","LU0432979614.USD","SG9999001176.USD","LU2362541513.USD","BBH","LU0256863811.USD","IE00B19Z3B42.SGD","IE00B894F039.SGD","LU0320765992.SGD","IBBQ","LU0109394709.USD","IBB","LU0289739699.SGD","LU0058720904.USD","LU2468319806.SGD","LU1674673428.USD","LU1778281490.HKD","BIB","BK4567","SG9999013999.USD","IE00B19Z9Z06.USD","LU0079474960.USD","VRTX","LU0234570918.USD","LU2362540622.SGD","LU1035775433.USD","TBXU","IDNA","LU2417539215.USD","IE0002141913.USD","IE00B2B36J28.USD","LU0889565916.HKD","LU2362541273.HKD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662749358","title":"Revolution Medicines Prices Metastatic Pancreatic Cancer Drug Rasonque at $39,800 a Month","url":"https://stock-news.laohu8.com/highlight/detail?id=2662749358","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662749358?lang=en_us&edition=fundamental","pubTime":"2026-08-27 02:20","pubTimestamp":1787768430,"startTime":"0","endTime":"0","summary":"Revolution Medicines'  once-daily oral Rasonque tablets for the treatment of metastatic pancreatic cancer are available in the US at a price of $39,800 for a 30-day supply, the company said Wednesday in a regulatory filing.The US Food and Drug Administration approved Rasonque for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or who are not candidates for multiagent systemic therapy.Price: 215.95, Change: +4.57, Percent Change: +2.16","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","CANC","IE00B4R5TH58.HKD","LU0109394709.USD","LU0320765992.SGD","IE0009354923.USD","IE00BFTCPJ56.SGD","IDNA","IE00B2B36J28.USD","LU0889565916.HKD","IE00BJJMRZ35.SGD","PTH","BBH","RVMD","IE00BJT1NW94.SGD","IE0002141913.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662746776","title":"Revolution Medicines to Charge $39,800 a Month for Pancreatic Cancer Drug, Bloomberg Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2662746776","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662746776?lang=en_us&edition=fundamental","pubTime":"2026-08-27 02:02","pubTimestamp":1787767375,"startTime":"0","endTime":"0","summary":"Price: 215.72, Change: +4.34, Percent Change: +2.05","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBH","IE00BFTCPJ56.SGD","LU0320765992.SGD","IE0009355771.USD","RVMD","IE0009354923.USD","CANC","IE00B2B36J28.USD","BK4139","IE0002141913.USD","IDNA","IE00BJT1NW94.SGD","LU0109394709.USD","LU0889565916.HKD","PTH","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662462057","title":"Revolution Medicines - Rasonque is NOW Commercially Available in the U.S. at a Wholesale Acquisition Cost of $39,800 for a 30-Day Supply - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2662462057","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662462057?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:56","pubTimestamp":1787766961,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0O4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CANC","LU0889565916.HKD","BK4139","IE00BFTCPJ56.SGD","IE0009354923.USD","IDNA","IE0002141913.USD","RVMD","PTH","LU0109394709.USD","IE0009355771.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU0320765992.SGD","IE00BJJMRZ35.SGD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662746411","title":"Revolution Medicines Posts Investor Presentation on Rasonque FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2662746411","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662746411?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:45","pubTimestamp":1787766356,"startTime":"0","endTime":"0","summary":"Revolution Medicines posts investor presentation on RASONQUE FDA approvalRevolution Medicines released an investor presentation covering U.S. FDA approval of RASONQUE (daraxonrasib) for metastatic pan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL4qMXCX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANC","LU0889565916.HKD","RVMD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","IE0009354923.USD","IDNA","BK4139","PTH","IE00B4R5TH58.HKD","IE0009355771.USD","BBH","IE00BFTCPJ56.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662797746","title":"Revolution Medicines prices Rasonque at $39,800 for 30-day supply","url":"https://stock-news.laohu8.com/highlight/detail?id=2662797746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662797746?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:45","pubTimestamp":1787766320,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) disclosed that following FDA approval of Rasonque for the treatment of adult patients with metastatic pancreatic adenoc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-prices-rasonque-at-39800-for-30-day-supply-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-prices-rasonque-at-39800-for-30-day-supply-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","CANC","IEIH","RVMD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IE0009354923.USD","PTH","MEDI","BBP","BK4585","IE00BJJMRZ35.SGD","LABU","MRNX","TBXU","IE00B4R5TH58.HKD","NVIB","IE0009355771.USD","IE00BFTCPJ56.SGD","RSPH","PSCH","GNMX","LFSC","LU0320765992.SGD","BK4588","IE0002141913.USD","TECB","IYH","XLVX","IDNA","PINK","BMED","SYNB","IBB","LU0889565916.HKD","FRTY","BK4139","GDOC","BBH","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662074659","title":"Revolution Medicines announces FDA approval of Rasonque in adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2662074659","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662074659?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:05","pubTimestamp":1787763925,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) announced that the U.S. Food and Drug Administration has approved RASONQUE once-daily oral tablets, for the treatment o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-announces-fda-approval-of-rasonque-in-adults-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-announces-fda-approval-of-rasonque-in-adults-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","LU0109394709.USD","PINK","MEDI","IYH","BK4585","MRNX","BK4588","IE00B2B36J28.USD","RVMD","LFSC","IE0002141913.USD","IE00BFTCPJ56.SGD","BK4139","IE00BJJMRZ35.SGD","GNMX","LABU","IEIH","BBP","LU0320765992.SGD","XLVX","IE0009355771.USD","IBB","FRTY","NVIB","SYNB","BBH","TBXU","IDNA","MRNY","CANC","IE0009354923.USD","LU0889565916.HKD","PTH","GDOC","PSCH","TECB","IE00BJT1NW94.SGD","RSPH","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662745207","title":"Revolution Medicines, - Rasonque 300 Mg Once-Daily Oral Tablets NOW Available in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2662745207","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662745207?lang=en_us&edition=fundamental","pubTime":"2026-08-27 00:59","pubTimestamp":1787763576,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nTUA6XRCYX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B2B36J28.USD","PTH","BK4139","IE0002141913.USD","LU0889565916.HKD","IE00BJT1NW94.SGD","LU0320765992.SGD","BBH","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IDNA","LU0109394709.USD","IE00B4R5TH58.HKD","IE0009355771.USD","RVMD","CANC","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662452007","title":"U.S. FDA Approves Revolution Medicines’ Rasonque™ (Daraxonrasib), the First Broad Ras-Targeted Medicine in Metastatic Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662452007","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662452007?lang=en_us&edition=fundamental","pubTime":"2026-08-27 00:59","pubTimestamp":1787763576,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nTUA6XRCYX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTH","IE00BJJMRZ35.SGD","CANC","IDNA","IE0002141913.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0109394709.USD","LU0889565916.HKD","RVMD","BBH","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4139","IE0009355771.USD","IE0009354923.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662759746","title":"U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662759746","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662759746?lang=en_us&edition=fundamental","pubTime":"2026-08-27 00:59","pubTimestamp":1787763540,"startTime":"0","endTime":"0","summary":"RASONQUE is indicated for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or who are not candidates for multiagent syste","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/26/3351615/0/en/u-s-fda-approves-revolution-medicines-rasonque-daraxonrasib-the-first-broad-ras-targeted-medicine-in-metastatic-pancreatic-cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0124384867.USD","LU1854103824.USD","RVMD","LABU","IE0009354923.USD","LU0320765992.SGD","ONG","BK4613","BK4009","ONX","LU0053671581.USD","IE00BJJMRZ35.SGD","LU1720051017.SGD","LU1861220033.SGD","TTD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU1978683503.SGD","BK4225","LU0724618433.USD","IE0002141913.USD","LU1861219969.SGD","PFS","BK4023","LU0210528500.USD","SRET","BK4512","TTDU","IE0009355771.USD","BK4141","CANC","IE00BZ199S13.USD","L","LU1720051108.HKD","BK4605","LU0889565916.HKD","ITT","LU2360107325.USD","HR","LU0109394709.USD","BK4139","LU2487616109.SGD","IE00BD6J9T35.USD","BK4585","BBH","ON","IDNA","PTH","BK4588","EMA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}